Abstract:This figure presents a worldwide vision illustrating the relationship between the frequencies of HLA‐C04 and HLA‐A02 alleles and their respective associations with COVID‐19 susceptibility and mortality rates across different regions. The darker shaded areas represent regions with moderate‐to‐high frequencies of selected alleles and higher rates of susceptibility and mortality from COVID‐19. However, there are exceptions, such as China, where despite a higher frequency of HLA‐C04, lower incidence and mortality rates are observed. This suggests the influence of factors beyond host genetics, including government policies (e.g., Zero‐COVID‐19 policy), timely implementation of quarantine measures, access to vaccines and treatments, and well‐equipped medical facilities. Similarly, the figure highlights the protective effect of HLA‐A02 allele, which is associated with lower COVID‐19 susceptibility and reduced mortality rates. However, variations in this protective effect are observed, possibly due to the aforementioned contributing factors. Background The COVID‐19 pandemic has had a profound global impact, with variations in susceptibility, severity, and mortality rates across different regions. While many factors can contribute to the spread and impact of the disease, specifically human leukocyte antigen (HLA) genetic variants have emerged as potential contributors to COVID‐19 outcomes. Methods In this comprehensive narrative review, we conducted a thorough literature search to identify relevant studies investigating the association between HLA genetic variants and COVID‐19 outcomes. Additionally, we analyzed allelic frequency data from diverse populations to assess differences in COVID‐19 incidence and severity. Results Our review provides insights into the immunological mechanisms involving HLA‐mediated responses to COVID‐19 and highlights potential research directions and therapeutic interventions. We found evidence suggesting that certain HLA alleles, such as HLA‐A02, may confer a lower risk of COVID‐19, while others, like HLA‐C04, may increase the risk of severe symptoms and mortality. Furthermore, our analysis of allele frequency distributions revealed significant variations among different populations. Conclusion Considering host genetic variations, particularly HLA genetic variants, is crucial for understanding COVID‐19 susceptibility and severity. These findings have implications for personalized treatment and interventions based on an individual's genetic profile. However, further research is needed to unravel the precise mechanisms underlying the observed associations and explore the potential for targeted therapies or preventive measures based on HLA genetic variants.

Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection

Relationships Between Polymorphisms in HLA-G 3'UTR Region and COVID-19 Disease Severity

A Molecular HLA Typing Study

Relationship Between HLA Genetic Variations, COVID-19 Vaccine Antibody Response, and Risk of Breakthrough Outcomes

The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review

The HLA-B –21 M/T dimorphism associates with disease severity in COVID-19

HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection

Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

The Polymorphisms of HLA Class Ⅰ and Ⅱalleles Were Not Associated with Severe Acute Respiratory Syndrome among Recovered Patients in Beijing: a Case-Control Study

Analysis of KIR and HLA Polymorphism in Chinese Individuals With COVID‐19

Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

COVID-19 neutralizing antibodies predict disease severity and survival

Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity

HLA class II DRB1, DQA1, DQB1 loci in patients with HIV infection and tuberculosis in a Latvian cohort group

Impact of HLA Alleles on COVID-19 Severity in Kidney Transplant Recipients: A Single-Center Study

Association of Human Leukocyte Antigen Alleles with COVID-19 Severity and Mortality in a Spanish Population

Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients

Association between human leukocyte antigen alleles and COVID-19 disease severity

Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19)

The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population